Milestone Pharmaceuticals Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MIST Nasdaq 2830 www.milestonepharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Aug 4th, 2026 2:01 pm
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST) - Jul 29th, 2026 7:35 am
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 7:30 pm
Milestone (MIST) Q1 2026 Earnings Transcript - Jun 1st, 2026 8:31 am
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer - May 21st, 2026 7:00 am
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability - May 15th, 2026 4:49 am
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - May 14th, 2026 6:30 am
Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:44 pm
Milestone Pharmaceuticals Inc (MIST) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... - May 13th, 2026 5:00 pm
Why Milestone Pharmaceuticals Stock Wilted on Wednesday - May 13th, 2026 4:16 pm
Milestone Pharmaceuticals Q1 Earnings Call Highlights - May 13th, 2026 12:09 pm
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - May 13th, 2026 7:40 am
Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST) - May 13th, 2026 7:34 am
Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates - May 13th, 2026 6:20 am
Earnings Scheduled For May 13, 2026 - May 13th, 2026 5:11 am
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update - May 13th, 2026 5:11 am
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 - May 6th, 2026 6:00 am
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT - Apr 10th, 2026 6:00 am
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 7th, 2026 6:30 am
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies - Mar 31st, 2026 6:00 am